ORGO
Organogenesis Holdings Inc
NASDAQ: ORGO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.35
+2.17% today
Updated 2026-04-30
Market cap
$307.45M
P/E ratio
15.93
P/S ratio
0.55x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$2 – $7
Volume
1.4M
Organogenesis Holdings Inc (ORGO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2001 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.04M | $98.97M | $0.00 | $0.00 | $193.45M | $260.98M | $338.30M | $467.36M | $450.89M | $433.14M | $482.04M | $564.17M |
| Revenue growth (YoY) | — | +9407.7% | -100.0% | — | — | +34.9% | +29.6% | +38.2% | -3.5% | -3.9% | +11.3% | +17.0% |
| Cost of revenue | $1.19M | $46.45M | $208698.00 | $4.59M | $68.81M | $75.95M | $87.32M | $114.20M | $105.02M | $106.48M | $115.74M | $149.11M |
| Gross profit | $-153155.00 | $52.52M | $-208698.00 | $-4.59M | $124.64M | $185.03M | $250.98M | $353.16M | $345.87M | $326.66M | $366.30M | $415.06M |
| Gross margin | -14.7% | 53.1% | — | — | 64.4% | 70.9% | 74.2% | 75.6% | 76.7% | 75.4% | 76.0% | 73.6% |
| R&D | $1.58M | $3.88M | $6.28M | $9.06M | $10.74M | $14.80M | $20.09M | $30.74M | $39.76M | $44.38M | $50.27M | $44.54M |
| SG&A | $829299.00 | $25160.00 | $208700.00 | $4.59M | $161.96M | $198.63M | $200.76M | $244.68M | $279.00M | $264.53M | $290.69M | $326.24M |
| Operating income | $-2.56M | $-25160.00 | $208698.00 | $-4.59M | $-51.56M | $-29.85M | $26.70M | $72.22M | $22.30M | $12.53M | $-1.28M | $56.38M |
| Operating margin | -246.0% | -0.0% | — | — | -26.7% | -11.4% | 7.9% | 15.5% | 4.9% | 2.9% | -0.3% | 10.0% |
| EBITDA | — | — | $-1.75M | $-4.59M | $-46.92M | $-19.74M | $37.23M | $87.00M | $40.32M | $36.03M | $15.76M | $83.32M |
| EBITDA margin | 0.0% | 0.0% | — | — | -24.3% | -7.6% | 11.0% | 18.6% | 8.9% | 8.3% | 3.3% | 14.8% |
| EBIT | $-2.56M | $-25.58M | $-1.34M | $-4.59M | $-53.89M | $-29.56M | $29.04M | $70.32M | $22.29M | $12.58M | $-1.26M | $56.38M |
| Interest expense | $0.00 | $0.00 | $5.63M | $2.50M | $10.85M | $9.00M | $11.28M | $7.24M | $2.01M | $2.19M | $1.54M | $2.28M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.88M | $-25160.00 | $-208698.00 | $-2.09M | $-64.83M | $-38.71M | $17.23M | $94.20M | $15.53M | $4.95M | $861000.00 | $37.03M |
| Net income growth (YoY) | — | +99.1% | -729.5% | -903.3% | -2996.2% | +40.3% | +144.5% | +446.6% | -83.5% | -68.2% | -82.6% | +4201.0% |
| Profit margin | -276.5% | -0.0% | — | — | -33.5% | -14.8% | 5.1% | 20.2% | 3.4% | 1.1% | 0.2% | 6.6% |